Apolipoprotein CIII Is an Important Piece in the Type-1 Diabetes Jigsaw Puzzle

Valladolid-Acebes, I (author)

(creator_code:org_t)

2021-01-19
2021
English.
In: International journal of molecular sciences. - : MDPI AG. - 1422-0067. ; 22:2

Related links:: https://www.mdpi.com...; show more...; http://kipublication...; https://doi.org/10.3...; show less...

Abstract Subject headings

It is well known that type-2 diabetes mellitus (T2D) is increasing worldwide, but also the autoimmune form, type-1 diabetes (T1D), is affecting more people. The latest estimation from the International Diabetes Federation (IDF) is that 1.1 million children and adolescents below 20 years of age have T1D. At present, we have no primary, secondary or tertiary prevention or treatment available, although many efforts testing different strategies have been made. This review is based on the findings that apolipoprotein CIII (apoCIII) is increased in T1D and that in vitro studies revealed that healthy β-cells exposed to apoCIII became apoptotic, together with the observation that humans with higher levels of the apolipoprotein, due to mutations in the gene, are more susceptible to developing T1D. We have summarized what is known about apoCIII in relation to inflammation and autoimmunity in in vitro and in vivo studies of T1D. The aim is to highlight the need for exploring this field as we still are only seeing the top of the iceberg.

By the author/editor: Valladolid-Acebe ...; Berggren, PO; Juntti-Berggren, ...

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.